emphysema treatment breakthrough - Axtarish в Google
9 окт. 2024 г. · “We found that P63+ progenitor cell transplantation not only improved the lung function of patients with COPD, but also relieved their symptoms, ...
1 день назад · Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is used as a ...
25 янв. 2023 г. · With treatment using Zephyr Valves, a physician places an average of four valves to occlude airways leading to the targeted, hyper-inflated part ...
Experts hope that the one-off treatment, known as targeted lung denervation (TLD), will have permanent benefits and may replace the need for the long-term use ...
23 июл. 2024 г. · A new phase 3 study reveals that dupilumab significantly reduces the frequency of severe exacerbations and improves lung function in patients ...
9 июл. 2024 г. · Zephyr® Valves received breakthrough device designation and were approved by the FDA in 2018. The Zephyr Valve treatment helps patients breathe ...
Scientists are moving beyond stem cells to research the ability of fully mature lung cells in the hope that they will help repair tissue damage in patients ...
New Bronchodilators and Inhaled Steroids. The development of new bronchodilators and inhaled steroids has expanded the treatment options for COPD patients.
15 часов назад · Offering patients an injection is more effective than the current care of steroid tablets and cuts the need for further treatment by 30%, ...
26 авг. 2024 г. · Dupixent is the first newly approved treatment for COPD in more than a decade. Published data from the Phase 3 NOTUS clinical trial confirmed ... Try Rehab · Get Strategic · Bring Your Gear
Novbeti >

 -  - 
Axtarisha Qayit
Anarim.Az


Anarim.Az

Sayt Rehberliyi ile Elaqe

Saytdan Istifade Qaydalari

Anarim.Az 2004-2023